Breaking News

Increased Cases of Consumption of Restricted Drugs to Fuel Demand in Global Drugs of Abuse Testing Market

img

As indicated by the United Nations Office on Drugs and Crime, about five percent of the global grown-up population were under the influence of certain kind of restricted medication at least once in year 2015. That rate heightens exponentially in case we consider it within the U.S., a nation that has been defaced by the instances of substance abuse for a very long while. Rising in such cases are being seen in European countries as well and therefore, strong measures are currently being embraced by individual governments to beat this reason for sudden deaths among the grown-ups. Thus, the global drugs of abuse testing market is thriving. According to a recently published report by marketresearchreports.biz titled, “Drugs of Abuse Testing Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025.”

The market for drugs of abuse testing, which can be an in-house or onsite examination of drugs inside a human body, is picking up pace from various figures, for example, technological advancements in analyzers, better accessibility of prohibited drugs, and emphasis on work place screening among the urban population. The emergence of testing gadgets that are reducing the requirement, for an example of urine, salivation, or blood to be taken to a research center is anticipated as a noteworthy contributor for the drugs of abuse testing market. Then again, absence of awareness with respect to the accessibility of advanced drugs testing gadgets and consideration as an infringement of security rights in a few nations are a couple of restrictions hampering the development of the market.

Also Read:  Global Parkinsons Disease (PD) Drugs Market Will Grow At A CAGR Of 3.81% During The Period 2017-2021: Biogen, Eisai, Eli Lilly

Based on product type, the global drugs of abuse testing market is divided into three main sub segments namely, rapid testing devices, analyzers, and consumables. The analyzers product type segment is sub – segmented into chromatographic devices, immunoassay analyzers, and breathe analyzers. The rapid testing devices product type segment is sub-divided into oral fluid testing devices and urine testing devices. The consumables product type segment is segmented further as fluid collection devices and others. The market is analyzed further in terms of sample type. On the basis of sample type, the market is categorized into breath, hair & sweat, saliva, urine, and blood. Based on testing type, the market his segregated into criminal justice testing, pain management testing, and work place screening. As per the end users the market is divided into diagnostics laboratories, hospitals, forensic laboratories, and on-the-spot testing.

Also Read:  Check out the latest in Unified Monitoring Sector in Global Industry

For Sample Copy, click here: https://www.marketresearchreports.biz/sample/sample/186329

Based on geography, the global drugs of abuse testing market has been classified into five locales: Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. North America represented a 49.3% of the aggregate demand in 2016, trailed by Europe. Rise in demand for quick testing gadgets in North America is high as the government is regularizing the rules for unlawful consumption of drugs.

Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Drägerwerk AG & Co. KGaA, Siemens Healthineers, Danaher Corporation (Beckman Coulter, Inc.), Laboratory Corporation of America Holdings, and Abbott Laboratories are among the key players leading the global drugs of abuse testing market.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz

Email

Go to website

WP Facebook Auto Publish Powered By : XYZScripts.com